Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United States
The DOI matches its Crossref record.
Abstract
BACKGROUND: Highly active antiretroviral therapy (HAART) became standard for HIV in 1996. Studies at that time showed that most people infected with HIV had initiated HAART, but that members of minority groups and poor people had lower HAART use. It is not known whether high levels of HAART use have been sustained or whether socioeconomic and racial disparities have diminished over time. OBJECTIVES: To determine the proportion of patients who had received and were receiving HAART by January 1998, and to evaluate predictors of HAART receipt. DESIGN AND PARTICIPANTS: Prospective cohort study of a national probability sample of 2267 adults receiving HIV care who completed baseline, first follow-up, and second follow-up interviews from January 1996 to January 1998. MAIN OUTCOME VARIABLES: Proportion currently using HAART at second follow-up (August 1997 to January 1998), contrasted with the cumulative proportions using HAART at any time before January 1998 and before December 1996. ANALYSES: Bivariate and multiple logistic regression analysis of population characteristics predicting current use of HAART at the time of the second follow-up interview. RESULTS: The proportion of patients ever having received HAART increased from 37% in December 1996 to 71% by January 1998, but only 53% of people were receiving HAART at the time of the second follow-up interview. Differences between sociodemographic groups in ever using HAART narrowed after 1996. In bivariate analysis, several groups remained significantly less likely to be using HAART at the time of the second follow-up interview: blacks, male and female drug users, female heterosexuals, people with less education, those uninsured and insured by Medicaid, those in the Northeast, and those with CD4 counts of >/=500 cells/microl (all p <.05). Using multiple logistic regression analysis, low CD4 count (for CD4 <50 cells/microl: odds ratio [OR], 3.20; p <.001) remained a significant predictor of current HAART use at the time of the second follow-up interview, but lack of insurance (OR, 0.71; p <.05) predicted not receiving HAART. CONCLUSIONS: The proportion of persons under HIV care in the United States who had ever received HAART increased to over 70% of the affected population by January 1998 and the disparities in use between groups narrowed but did not disappear. However, nearly half of those eligible for HAART according to the U.S. Department of Health and Human Services guidelines were not actually receiving it nearly 2 years after these medications were first introduced. Strategies to promote the initiation and continuation of HAART are needed for those without contraindications and those who can tolerate it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cancer risk in people infected with human immunodeficiency virus in the United States
Engels, E. A., Biggar, R. J., Hall, H. I., Cross, H., Crutchfield, A., Finch, J. L., Grigg, R., Hylton, T., Pawlish, K. S., McNeel, T. S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23487 · Cited by 768
A prospective study of predictors of adherence to combination antiretroviral medication
Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Kaplan, A. H., & Wenger, N. S. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.11214.x · Cited by 509
Self-citationThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444
Determinants of survival following HIV-1 seroconversion after the introduction of HAART
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14570-9 · Cited by 369
Technological innovation and inequality in health
Glied, S., & Lleras-Muney, A. (2008) · Demography · doi:10.1353/dem.0.0017 · Cited by 304
Metadata
- Authors
- Cunningham, W. E., Markson, L. E., Andersen, R. M., Crystal, S. H., Fleishman, J. A., Golin, C., Gifford, A., Liu, H. H., Nakazono, T. T., Morton, S., Bozzette, S. A., Shapiro, M. F., & Wenger, N. S.
- Venue
- Journal of Acquired Immune Deficiency Syndromes
- Published
- 2000-10
- Volume
- 25
- Issue
- 2
- Pages
- 115-123
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2417580446
- Cited by
- 120
- References
- 0
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United States. https://app.cochat.ai/papers/10.1097/00042560-200010010-00005
- The paper
- Cunningham, W. E., Markson, L. E., Andersen, R. M., Crystal, S. H., Fleishman, J. A., Golin, C., Gifford, A., Liu, H. H., Nakazono, T. T., Morton, S., Bozzette, S. A., Shapiro, M. F., & Wenger, N. S. (2000). Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United States. Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00042560-200010010-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.